Ropes & Gray LLP
Best known for its life sciences and tech sector-related IP credentials, Ropes & Gray LLP‘s team in Shanghai has a broad IP practice with a particular focus on transactional mandates. The experienced Geoffrey Lin has extensive experience handling domestic and cross-border IP matters.
Legal 500 Editorial commentary
Key clients
- Everest Medicines
- LianBio
- Pediatrix Therapeutics
- Tianjin Adicon Limited
- Luca Healthcare
- Bain Capital Life Sciences/Bain Capital Private Equity
- Hutchmed
Work highlights
- Advised Hutchmed on its license to Takeda to develop and commercialize Fruquintinib outside of China for a total of $1.13bn.
- Advising Everest Medicines on a commercial agreement with Accelerate Technologies for COVID-19 products and with Gilead Sciences for the development of Trodelvy (a cancer drug) for up to $455m.
- Representing Pediatrix Therapeutics in a license agreement with Aclaris Therapeutics, a clinical-stage biopharma company focused on developing novel drug candidates for immuno-inflammatory diseases for ATI-1777 in Greater China for payments of up to $91m.
Lawyers
Leading individuals
Practice head
The lawyer(s) leading their teams.
Geoffrey Lin